Market Outlook

According to Future Market Consulting analysis, Global Forensic Genomics Market size was valued at USD 8.21 Billion in 2021 and is projected to reach USD 13.35 Billion by 2030, growing at a CAGR of 3.14 % from 2022 to 2030.

In the growing field of personalized medicine, an individual's genetic sequence is utilized to reach conclusions regarding prevention of illness, diagnosis, and treatment. Clinicians can choose the optimal drug or therapy for the patient based on their genetic profile and administer it in accordance with the suggested dose or schedule. Personalized medicine is advancing as a result of data from Human Genome Project. Investigation biological genealogies, also referred as forensic genomics, is a new technique for discovering criminals or victim in criminal investigations based on the use of genetic information from direct-to-consumer companies. To identify unknown people, forensic genomics analyses DNA segments known as identity-by-descent (IBD) sections, which demonstrate shared ancestry.

The market's expansion is hampered by a scarcity of certified and prospective professionals. Instruments and regulatory frameworks are quite expensive. When using genomic datasets for research, technical issues in massive database processing were discovered. The high spending of genetic technology may act as a marketing barrier as well. Despite the fact that the goal of forensic genomics is to shape the future of a global healthcare system, excessive equipment costs have limited its usage to only developed countries. As most firms employ advance sequencing technology in conjunction using consumer datasets, the forensic genomics market is likely to grow rapidly. The market may evolve in context of the limits of traditional testing procedures and the difficulties to validate alternative methodologies to improve investigations.

Key Players

• General Electric (GE) Co. (GE Healthcare)
• Eurofins Scientific Group (Eurofins Discovery)
• Gene by Gene, Ltd.
• Verogen, Inc.
• Agilent Technologies, Inc.
• Illumina, Inc.
• Neogen Corporation
• Thermo Fisher Scientific, Inc.

Segmentation

By Component

• Kits & Consumables
• Analyzers & Sequencers
• Software

By Method

• Capillary Electrophoresis
• Next-generation Sequencing
• PCR Amplification

By Application

• Criminal Testing
• Paternity & Familial Testing
• Bio-surveillance
• Others

By Region

North America

• S.
• Canada
• Mexico

Europe

• France
• UK
• Spain
• Germany
• Italy
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• South Korea
• Rest of Asia Pacific

Middle East & Africa

• GCC
• South Africa
• Rest of the MEA

South America

• Brazil
• Argentina
• Rest of South America